NORTHERN TRUST CORP - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 128 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q2 2023$120,581
+14.9%
148,865
-0.7%
0.00%
Q1 2023$104,906
+62.4%
149,865
+63.7%
0.00%
Q4 2022$64,614
-48.7%
91,522
+10.5%
0.00%
Q3 2022$126,000
+53.7%
82,803
+0.3%
0.00%
Q2 2022$82,000
-83.8%
82,538
-76.5%
0.00%
Q1 2022$506,000
-77.1%
351,533
-17.1%
0.00%
Q4 2021$2,214,000
-7.9%
424,192
+2.9%
0.00%
Q3 2021$2,404,000
-20.7%
412,272
+9.6%
0.00%
-100.0%
Q2 2021$3,031,000
-4.5%
376,087
-1.4%
0.00%0.0%
Q1 2021$3,175,000
+3.3%
381,608
-5.9%
0.00%0.0%
Q4 2020$3,074,000
-28.2%
405,515
+1.0%
0.00%0.0%
Q3 2020$4,279,000
-24.0%
401,441
+8.1%
0.00%0.0%
Q2 2020$5,627,000
+76.9%
371,226
-2.8%
0.00%0.0%
Q1 2020$3,181,000
-50.8%
381,865
-0.2%
0.00%0.0%
Q4 2019$6,469,000
-9.7%
382,794
-0.7%
0.00%
-50.0%
Q3 2019$7,161,000
-13.8%
385,677
+6.2%
0.00%0.0%
Q2 2019$8,311,000
+10.1%
363,274
+1.2%
0.00%0.0%
Q1 2019$7,549,000
+85.2%
359,134
+1.3%
0.00%
+100.0%
Q4 2018$4,076,000
-50.9%
354,492
-2.0%
0.00%
-50.0%
Q3 2018$8,300,000
+6.1%
361,631
+3.1%
0.00%0.0%
Q2 2018$7,823,000
+0.1%
350,809
+2.5%
0.00%0.0%
Q1 2018$7,819,000
-10.4%
342,201
+2.8%
0.00%0.0%
Q4 2017$8,722,000
+13.6%
332,923
-2.7%
0.00%0.0%
Q3 2017$7,681,000
-15.0%
342,142
+3.5%
0.00%
-33.3%
Q2 2017$9,038,000
+20.7%
330,466
+6.8%
0.00%
+50.0%
Q1 2017$7,485,000
+28.6%
309,306
+10.2%
0.00%0.0%
Q4 2016$5,822,000
-22.2%
280,563
+2.2%
0.00%0.0%
Q3 2016$7,486,000
+82.9%
274,639
-3.4%
0.00%
+100.0%
Q2 2016$4,093,000
-2.3%
284,386
-2.5%
0.00%0.0%
Q1 2016$4,191,000
-26.1%
291,654
+10.5%
0.00%
-50.0%
Q4 2015$5,672,000
+46.1%
263,908
+10.0%
0.00%
+100.0%
Q3 2015$3,883,000
-39.8%
239,991
-3.9%
0.00%
-50.0%
Q2 2015$6,449,000
+12.7%
249,850
-1.8%
0.00%0.0%
Q1 2015$5,723,000
+16.4%
254,353
-0.7%
0.00%
+100.0%
Q4 2014$4,915,000
-14.1%
256,146
-3.9%
0.00%
-50.0%
Q3 2014$5,724,000
+19.4%
266,458
+44.5%
0.00%
+100.0%
Q2 2014$4,793,000
+22.6%
184,354
+2.8%
0.00%0.0%
Q1 2014$3,910,000
+68.8%
179,274
-5.5%
0.00%0.0%
Q4 2013$2,316,000
+5.1%
189,790
+15.5%
0.00%0.0%
Q3 2013$2,204,000
+348.0%
164,308
+171.2%
0.00%
Q2 2013$492,00060,5810.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Birchview Capital, LP 225,239$1,295,1231.10%
CHARTIST INC /CA/ 67,073$385,6670.23%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders